Trials / Completed
CompletedNCT03535987
Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Male
- Age
- 51 Years
- Healthy volunteers
- Not accepted
Summary
To determine the feasibility of using myocardial PET imaging as a means to assess cardiovascular risk in men with prostate cancer planned for androgen- deprivation therapy with external beam radiation therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | myocardial PET imaging | using myocardial PET imaging as a means to assess cardiovascular risk in men with prostate cancer planned for androgen-deprivation therapy with external beam radiation therapy |
Timeline
- Start date
- 2018-01-19
- Primary completion
- 2019-04-19
- Completion
- 2019-10-19
- First posted
- 2018-05-24
- Last updated
- 2024-11-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03535987. Inclusion in this directory is not an endorsement.